Introduction
============

Depression is one of the most prevalent mental disorders, with an estimated global point prevalence of 4.7%, and it is the eleventh leading cause of the global disease burden.[@b1-ndt-14-459],[@b2-ndt-14-459] Even though depression can be diagnosed in a reliable manner, there still exist some problems in its early diagnosis and differential diagnosis.[@b3-ndt-14-459]

The Chinese Classification of Mental Disorders (CCMD-3) is the most commonly practiced mental classification in China, which was developed by the Chinese Society of Psychiatry.[@b4-ndt-14-459] The diagnostic criteria of depression in the CCMD-3 includes two essential parts, symptom and disease course, which are widely used to diagnose depression.[@b5-ndt-14-459],[@b6-ndt-14-459] Since CCMD-3 has proposed a two-week time as the standard of course of disease, patients with a series of depressive symptoms, such as depressed mood and feelings of guilt, and whose disease course lasts for more than 2 weeks, can be diagnosed with depression. In addition, to rapidly determine whether patients' symptoms are consistent with those of depression, the Hamilton Rating Scale for Depression (HAMD) is used to assess a representative series of depressive symptoms within the framework of a clinical interview with depressed patients.[@b7-ndt-14-459] In the diagnostic procedure of psychiatric disorders, the results of the CCMD-3 and HAMD could help psychiatrists distinguish depression from other psychiatric disorders (eg, anxiety, schizophrenia).[@b8-ndt-14-459],[@b9-ndt-14-459] Currently, several epidemiological studies have revealed that subsyndromal conditions with depressive mood also exist in the community without progressing into full-blown mood episodes.[@b10-ndt-14-459],[@b11-ndt-14-459] Such depressive moods could be improved within 2 weeks, which we define as transient depressive state (TDS). In clinical work, patients with depression need early drug or physical treatment for a better prognosis,[@b12-ndt-14-459] while patients with TDS can be observed temporarily without drug prescription or physiotherapy. Moreover, patients with TDS can mostly self-recover within 2 weeks, and it is unnecessary for them to consider the side effects of the treatment.[@b13-ndt-14-459] Because the treatment principles of depression and TDS are different, distinguishing TDS from depression in patients with depressive symptoms is of high significance. Meanwhile, the *Diagnostic and Statistical Manual of Mental Disorders-IV* and International Classification of Diseases-10 also establish a 2-week course as the main diagnostic point of depression, but CCMD-3, *Diagnostic and Statistical Manual of Mental Disorders-IV*, and International Classification of Diseases-10 all show little importance on the diagnosis of patients with depressive symptoms if their disease course had not reached 2 weeks when they came to visit the doctor; this made the differential diagnosis of depression and TDS difficult.[@b14-ndt-14-459]

On this basis, we try to solve the problem based on analysis of serum indicators. Currently, changes of serum indicators in patients with depression including the reduction of neurotrophic factors,[@b15-ndt-14-459] upregulation of inflammatory factors,[@b16-ndt-14-459] and increase of cortisol[@b17-ndt-14-459] have been widely studied. Although the existing result are not consistent, we have referred to a large number of mainstream literature and selected 9 recognized indicators including BDNF, GDNF, FGF-2, VEGF, IL-1β, IL-6, IL-10, TNF-α, and cortisol. Notwithstanding that TDS is similar to depression, it is still unknown whether these serum indicators show similar changes in TDS, whether these serum indicators behave differently between the two conditions, and whether these indicators could help us to distinguish depression from TDS. Additionally, due to the high incidence of depression and TDS in elderly people, we selected elderly patients for observation. In this report, we analyzed 9 selected serum indicators in elderly patients with depression and patients with TDS. Afterward, the logistic regression model was established and ROC curves were drawn in order to explore their application value in the differential diagnosis of geriatric depression and TDS, as well as provide evidence for treatment.

Patients and methods
====================

Participants
------------

Two hundred seventy-four in- and out-patients were recruited for this study from the Affiliated Hospital of Jiangsu University. The inclusion criteria were as follows: 1) age \>65 years, 2) HAMD-24 scores ≥8, 3) on the first episode and treatment-naive, 4) coming to visit on the first day of the episode, and 5) temporarily refusing to be treated within 2 weeks of their course of the disease. Patients with any physical diseases (eg, organic brain diseases, tumor, thyroid disease, cardiovascular and autoimmune diseases), or history of familial psychiatric disorders were excluded from this study. Afterward, we followed up all participants during the following 2 weeks, and the retrospective diagnoses were made according to the CCMD-3 after the follow-up. According to their actual retrospective results of disease after a 2-week course, patients with depressive symptoms lasting for 2 weeks were diagnosed with depression, and patients with depressive symptoms who self-recovered within 2 weeks were diagnosed with TDS. The 274 elderly patients were divided into 144 patients with depression and 130 patients with TDS. Afterward, 90 patients with depression and 90 patients with TDS were randomly selected to build the diagnostic model, and another 54 patients with depression and 40 patients with TDS were used to validate our model.

The Institutional Review Board of the Affiliated Hospital of Jiangsu University approved the research protocol, and all participants provided written informed consent.

Clinical examinations of depression-related serum indicators
------------------------------------------------------------

Following an overnight fast, 5 mL of venous blood from participants was collected between 7 and 9 am. After collection, the blood samples were kept at room temperature for 1 hour before separation of the serum by centrifugation at 3,000 rpm for 20 minutes at 4°C. Serum samples were aliquoted and stored at −80°C until further analysis. The levels of BDNF, GDNF, FGF-2, VEGF, IL-1β, IL-6, IL-10, TNF-α, and cortisol were measured using enzyme-linked immunosorbent assay kits ([Table S1](#SD1-ndt-14-459){ref-type="supplementary-material"}) according to the manufacturer's instructions. All samples were examined by an operator who was blinded to the clinical status of the participants.

Statistical analysis
--------------------

SPSS 19.0 statistical software (SPSS, Inc., Chicago, IL, USA) was employed to analyze significant differences in the assay data. The data are reported as the mean ± standard deviation. Independent sample *t*-test, *χ*^2^ test, and rank sum test were used to examine differences in demographic data and selected serum indicators between the two groups. Then, the 9 serum indicators were used as covariates and diagnostic results of disease were used (depression =1, TDS =0) as dependent variables; forward logistic stepwise regression analysis was used to screen serum indicators to determine the final modeling indices. For each single index screened out by logistic regression and the detection level of its new variables as test variables and diagnostic results of disease as state variables, subjects' receiver operating characteristic (ROC) curve was drawn. Next, according to the logistic model and area under the ROC curve (AUC), the diagnostic value of combined detection for depression was evaluated. The results were considered significant at *P*\<0.05.

Results
=======

Results of demographic data and serum indicators
------------------------------------------------

As shown in [Table 1](#t1-ndt-14-459){ref-type="table"}, there were no significant differences in the sex, age, height, weight, years of schooling, and HAMD scores between the two groups. For the 9 screening serum indicators, the serum levels of BDNF, GDNF, and VEGF in the depression group were lower than those in the TDS group (*P*\<0.05), and the serum levels of IL-1β and cortisol in the depression group were higher than those in the TDS group (*P*\<0.05). However, there were no differences in the serum levels of FGF-2, IL-6, IL-10, and TNF-α (*P*\>0.05).

Logistic regression analysis of serum indicators
------------------------------------------------

In order to build the diagnostic model, 90 patients with depression and 90 patients with TDS were used. The 9 serum indicators were analyzed by forward logistic stepwise regression analysis, and the results are shown in [Table 2](#t2-ndt-14-459){ref-type="table"}. Only three independent variables, BDNF, IL-1β, and cortisol, were entered into the logistic regression equation. The partial regression coefficients were −0.018, 0.256, and 0.093, respectively, and their corresponding *P*-values were 0.001, \<0.001, and 0.003, respectively. The corresponding regression equation was as follows: $$Y = 1/\lbrack 1 + e^{- ( - 16.258 - 0.018\ (\text{BDNF}) + 0.256\ (\text{IL-}1\beta) + 0.093(\text{Cortisol}))}\rbrack$$

ROC curve analysis of 3 serum indicators by single detection and combined detection
-----------------------------------------------------------------------------------

[Figure 1A--D](#f1-ndt-14-459){ref-type="fig"} shows the ROC curves of the logistic regression models of 3 serum indicators by single detection and combined detection. The sensitivity and specificity of each serum marker for single detection and combined detection and AUC are shown in [Table 3](#t3-ndt-14-459){ref-type="table"}. The AUC of combined detection was 0.926, suggesting that combined detection had a better diagnostic rate than single detection, and its diagnostic sensitivity and specificity were 95.5% and 80.0%, which was the best model compared to others. According to the result of the best Youden Index, the corresponding cut point of combined detection for the diagnosis of depression was defined as a *Y*-value \>0.306.

Evaluation of logistic regression model
---------------------------------------

To further test the accuracy of the combined detection model, another 54 patients with depression and 40 patients with TDS were included in the analysis. The *P*-value of each patient was calculated according to the logistic regression equation. As shown in [Table 4](#t4-ndt-14-459){ref-type="table"}, compared to the actual diagnosis results made after 2 weeks, the diagnosis accuracy of the combined detection model was 89.36%.

Discussion
==========

TDS is a transient, negative emotional state caused by certain events or situations, and it is associated with stress and can largely be overcome through self-recovery within 2 weeks.[@b6-ndt-14-459] Due to the similarity of its symptoms with those of depression, and given the minor importance given by of the CCMD-3 and HAMD for their differential diagnosis at an early stage, the identification of depression and TDS has become a major difficulty in the field of neuropsychiatry, which had led to great difficulty in the treatment of depression and TDS. In this study, we innovatively combined observed multiple selected indicators and demonstrated, for the first time, that the logistic regression model and ROC curves based on BDNF, IL-1β, and cortisol can provide insight into differential diagnosis of geriatric depression and TDS.

Because of the high incidence rates of discord between children, death of relatives and inadaptability to life after retirement, the elderly bear more stress than younger groups, and thus constitute a large proportion of the population affected by depression and TDS.[@b18-ndt-14-459]--[@b20-ndt-14-459] Thus, we chose elderly patients over 65 years of age as participants; we then divided them into depression and TDS groups, according to whether their depressive symptoms could be self-recovered from in 2 weeks of their course without drug or physical treatment. On this basis, we analyzed 9 selected serum indicators and found that the levels of the serum indicators were indeed different between the two groups. Afterward, serum indicators in 90 patients with depression and 90 patients were screened using logistic regression, and three indices were screened out (BDNF, IL-1β, and cortisol) to build the logistic model. Finally, another 54 patients with depression and 40 patients with TDS were used to validate our model.

So far, several reports have demonstrated that BDNF, IL-1β, and cortisol have significant value in the pathogenesis of depression. BDNF, as the core factor of the neurotrophic hypothesis, is involved in synaptic plasticity and the survival of neurons.[@b21-ndt-14-459] Martocchia et al[@b22-ndt-14-459] found that the decreased BDNF serum levels in depressed elderly subjects increased after antidepressant treatment. Moreover, IL-1β and cortisol were demonstrated to be associated with the apoptosis of hippocampus cells,[@b23-ndt-14-459],[@b24-ndt-14-459] and many studies have attested that the serum levels of IL-1β and cortisol levels in depression patients were higher than those in healthy controls and decreased significantly after antidepressant treatment.[@b25-ndt-14-459],[@b26-ndt-14-459] According to the differences in the serum levels of BDNF, IL-1β, and cortisol between patients with depression and TDS showed in our results, we can infer that compared to patients with TDS, the degree of neuronal damage in patients with depression was more serious and more difficult to reverse, and it seemed to provide us with an explanation of why the depressive symptoms in TDS showed recovery within 2 weeks without medication, which needs further animal experiments to verify. Meanwhile, because the depressive disease is based on a complex pathophysiological process, single serum indicators cannot fully explain the change and development of the disease; thus, serum biomarker variables were combined to optimize sensitivity and specificity. The ROC curves based on BDNF, IL-1β, and cortisol showed the best sensitivity and specificity, and compared to actual diagnostic results, the diagnostic accuracy of our model reached 89.36%, which can be regarded as having clinically practical values.

Conclusion
==========

Our research is a preliminary retrospective analysis, and a number of issues could influence the interpretation of our results. A few limitations of this study should be noted. Although the standard course of 2 weeks for depressive symptoms was stipulated in the CCMD-3 and is a view commonly held by psychiatrists, there is no abundant proof for the length of this standard course; thus, this gold standard for the diagnosis of depression and TDS may not completely accurate. However, we did conduct a late follow-up after this experiment was over and demonstrated that our diagnosis was not problematic. Additionally, due to the complexity of the pathogenesis of depression, the 9 indicators we chose at the beginning is far from enough, and a more sensitive and more specific logistic model and ROC curve must exist, which requires further exploration. Notwithstanding these limitations, this study provides a more conducive method to the distinguish geriatric depression from TDS at an early stage. Once validated, substratification of geriatric depression/TDS patients based on composite biomarker and clinical assessment readouts could support psychiatrists in their diagnosis and treatment decision process and increase the rationality of treatment.

Supplementary material
======================

###### 

Detailed list of ELISA kits

  Name       Company                                                      Catalog number
  ---------- ------------------------------------------------------------ ----------------
  BDNF       Aviva Systems Biology, San Diego, CA, USA                    OKBB00127
  GDNF       Cusabio Biotech Co. Ltd, Wuhan, People's Republic of China   CSB-E04565h
  FGF-2      Aviva Systems Biology, San Diego, CA, USA                    OKAA00030_48W
  VEGF       Cusabio Biotech Co. Ltd, Wuhan, People's Republic of China   CSB-E11718h
  IL-1β      Cusabio Biotech Co. Ltd, Wuhan, People's Republic of China   CSB-E08053h
  IL-6       Cusabio Biotech Co. Ltd, Wuhan, People's Republic of China   CSB-E04638h
  IL-10      Cusabio Biotech Co. Ltd, Wuhan, People's Republic of China   CSB-E04593h
  TNF-α      Cusabio Biotech Co. Ltd, Wuhan, People's Republic of China   CSB-E04740h
  Cortisol   Cusabio Biotech Co. Ltd, Wuhan, People's Republic of China   CSB-E05111h

**Abbreviation:** ELISA, enzyme-linked immunosorbent assay.
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![ROC curve of 3 serum indicators of single detection and combined detection.\
**Notes:** (**A**) ROC curve of BDNF. (**B**) ROC curve of IL-1β. (**C**) ROC curve of cortisol. (**D**) ROC curve of combined detection.\
**Abbreviation:** ROC, receiver operating characteristic.](ndt-14-459Fig1){#f1-ndt-14-459}

###### 

Analysis of demographic data and 9 serum indicators in the two groups

  Indexes groups       Depression group (n=144)   TDS group (n=130)   *χ*^2^ or *t*   *P*-value
  -------------------- -------------------------- ------------------- --------------- ---------------------------------------------------
  Sex (M/F)            70/74                      62/68               0.373           0.541[a](#tfn1-ndt-14-459){ref-type="table-fn"}
  Age (years)          72.2±11.6                  73.6±9.8            1.073           0.284[b](#tfn2-ndt-14-459){ref-type="table-fn"}
  Height (cm)          161.6±9.7                  159.5±10.2          1.746           0.082[b](#tfn2-ndt-14-459){ref-type="table-fn"}
  Weight (kg)          69.2±12.3                  66.3±14.6           1.784           0.076[b](#tfn2-ndt-14-459){ref-type="table-fn"}
  Years of schooling   10.5±5.2                   11.7±7.3            1.578           0.116[b](#tfn2-ndt-14-459){ref-type="table-fn"}
  HAMD scores          15.8±9.3                   17.5±7.8            1.629           0.104[b](#tfn2-ndt-14-459){ref-type="table-fn"}
  BDNF (pg/mL)         251.48±62.32               293.33±85.62        4.665           0.001[b](#tfn2-ndt-14-459){ref-type="table-fn"}
  GDNF (pg/mL)         93.01±18.64                101.16±31.29        2.482           0.013[b](#tfn2-ndt-14-459){ref-type="table-fn"}
  FGF-2 (pg/mL)        192.54±58.72               199.17±66.42        1.148           0.252[b](#tfn2-ndt-14-459){ref-type="table-fn"}
  VEGF (pg/mL)         236.93±99.90               261.21±77.11        2.234           0.026[b](#tfn2-ndt-14-459){ref-type="table-fn"}
  IL-1β (pg/mL)        48.69±7.03                 37.87±6.58          13.113          0.027[c](#tfn3-ndt-14-459){ref-type="table-fn"}
  IL-6 (pg/mL)         12.14±6.33                 10.92±5.64          1.677           0.055[c](#tfn3-ndt-14-459){ref-type="table-fn"}
  IL-10 (pg/mL)        17.55±9.78                 19.42±7.15          1.790           0.082[c](#tfn3-ndt-14-459){ref-type="table-fn"}
  TNF-α (pg/mL)        31.43±7.87                 29.75±10.64         1.495           0.130[b](#tfn2-ndt-14-459){ref-type="table-fn"}
  Cortisol (ng/mL)     117.72±16.25               102.70±17.71        7.321           \<0.001[b](#tfn2-ndt-14-459){ref-type="table-fn"}

**Notes:**

*χ*^2^ test.

Independent samples *t*-test.

Rank sum test.

**Abbreviations:** HAMD, Hamilton Rating Scale for Depression; TDS, transient depressive state.

###### 

Variables in logistic regression equation

  Steps                                              Variables   B        SE       Wals     *df*      Sig       Exp (B)
  -------------------------------------------------- ----------- -------- -------- -------- --------- --------- ---------
  Step 1[a](#tfn5-ndt-14-459){ref-type="table-fn"}   IL-1β       0.260    0.039    48.026   1         \<0.001   1.306
  Constant                                           −11.282     1.638    47.426   1        \<0.001   0.000     
  Step 2[b](#tfn6-ndt-14-459){ref-type="table-fn"}   IL-1β       0.274    0.044    39.400   1         \<0.001   1.315
  Cortisol                                           0.074       0.017    19.820   1        0.005     1.077     
  Constant                                           −19.519     2.978    42.961   1        \<0.001   0.000     
  Step 3[c](#tfn7-ndt-14-459){ref-type="table-fn"}   BDNF        −0.018   0.005    12.820   1         0.001     0.983
  IL-1β                                              0.256       0.047    29.244   1        \<0.001   1.292     
  Cortisol                                           0.093       0.020    21.220   1        0.003     1.097     
  Constant                                           −16.258     3.078    27.897   1        \<0.001   0.000     

**Notes:**

Variables step 1: IL-1β.

Variables step 2: cortisol.

Variables step 3: BDNF.

**Abbreviations:** SE, standard error of the mean; Sig, significance; Exp, exponent.

###### 

Comparison of the sensitivity and specificity and the AUC of single serum marker detection and combined detection

  Indexes       BDNF    IL-1β   Cortisol   Combined detection
  ------------- ------- ------- ---------- --------------------
  AUC           0.714   0.903   0.778      0.926
  Sensitivity   0.611   0.833   0.878      0.935
  Specificity   0.689   0.778   0.523      0.800

**Abbreviations:** AUC, area under the ROC curve; ROC, receiver operating characteristic.

###### 

Diagnosis accuracy of the combined detection model

  Model diagnosis results   Actual diagnosis results   
  ------------------------- -------------------------- ----
  Depression                50                         6
  TDS                       4                          34
  Accuracy (%)              89.36                      

**Abbreviation:** TDS, transient depressive state.
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